Latest Regulatory News

Page 501 of 833
Invion Limited secures a pivotal FDA Orphan Drug Designation for its lead candidate INV043, targeting anal cancer with promising preclinical results and a fast-tracked development path.
Ada Torres
Ada Torres
20 Aug 2025
Invion Limited has disclosed that the US FDA granted Orphan Drug Designation for its lead cancer drug candidate INV043, explaining recent unusual trading activity in its shares. The company confirmed it was unaware of the FDA decision prior to its public release and has now complied with continuous disclosure rules.
Ada Torres
Ada Torres
20 Aug 2025
EV Resources has signed a strategic Memorandum of Understanding with Wogen Resources and Xcelsior Capital Advisors to fund and advance its Los Lirios Antimony Project in Mexico, aiming to establish a 100 tonne-per-day processing plant.
Maxwell Dee
Maxwell Dee
20 Aug 2025
Duxton Farms has received Foreign Investment Review Board approval for its strategic merger and updated its timetable for key shareholder and court approvals, alongside a $4.55 million capital raise.
Ada Torres
Ada Torres
20 Aug 2025
Neurizon Therapeutics reports encouraging topline results from its Phase 1 Open-Label Extension study of NUZ-001, demonstrating long-term safety and a significant survival advantage in ALS patients. These findings pave the way for the pivotal HEALEY ALS Platform Trial planned for late 2025.
Ada Torres
Ada Torres
20 Aug 2025
Vital Metals Limited has voluntarily suspended trading of its shares pending a key announcement on a capital raise, following an ASX price and volume query.
Maxwell Dee
Maxwell Dee
20 Aug 2025
LTR Pharma’s intranasal ED treatment SPONTAN achieves peak effect up to five times faster than oral tablets, according to new peer-reviewed clinical data published in a leading European journal.
Ada Torres
Ada Torres
20 Aug 2025
Lindian Resources has approved the Final Investment Decision for its Kangankunde Rare Earths Project, securing full funding and a strategic partnership with Iluka Resources. The company is raising A$91.5 million via institutional placement to advance development and expansion plans.
Maxwell Dee
Maxwell Dee
20 Aug 2025
Xamble Group Limited (ASX, XGL) has announced a pro-rata renounceable entitlement offer to raise up to A$1.36 million, including free attaching options exercisable until 2028. The offer is partially underwritten by Eli Capital Pty Limited and aims to accelerate platform growth and technology development.
Sophie Babbage
Sophie Babbage
20 Aug 2025
Novomatic AG has launched an unconditional A$1.00 per share cash takeover offer for all remaining shares in Ainsworth Game Technology Limited, representing a 35% premium to pre-announcement prices. The offer runs alongside a previously announced scheme and comes with unanimous support from Ainsworth's Independent Board Committee.
Victor Sage
Victor Sage
20 Aug 2025
TG Metals reports encouraging assay results from historical stockpiles and secures approvals for in-pit drilling at its Van Uden Gold Project, aiming to unlock near-term cash flow opportunities.
Maxwell Dee
Maxwell Dee
20 Aug 2025
Papyrus Australia has signed a binding term sheet with TBS Mining Solutions to produce a biodegradable version of the Collar Keeper® product, marking a significant step in commercialising sustainable mining solutions.
Maxwell Dee
Maxwell Dee
20 Aug 2025